California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

The state awarded a $50 million contract to produce less costly treatments, but moves by major suppliers might undercut the initiative before any new product emerges.
Double-Barreled Economic Threat Puts Congress on Edge

Double-Barreled Economic Threat Puts Congress on Edge

Republicans and Democrats disagree over how recent bank closures should impact the debt limit stalemate, and have taken divergent lessons from past economic crises.